A0A075B709_HUMAN Loading...

T cell receptor alpha joining 13 AlphaSync

AlphaFold DB , UniProt , Accession A0A075B709, Species HUMAN (Homo sapiens, Human), Gene TRAJ13, Length 21 aa.

>A0A075B709_HUMAN|A0A075B709|TRAJ13
XNSGGYQKVTFGTGTKLQVIP
Structure Viewer
Loading PAE data...
(Predicted Aligned Error values between residue pairs)
Error loading PAE data: please refresh the page.

 

Download Structure   AlphaSync Parameters   PDB   PAE   Table  
Site Residue pLDDT pLDDT confidence pLDDT10 pLDDT10 confidence SASA SASA [Ų] SASA10 SASA10 [Ų] RSA RSA unformatted RSA10 RSA10 unformatted Surface Surface10 (not used) Disorder (not used) Disorder Sec. str. Secondary structure Isomer Phi (φ) Psi (ψ) Omega (ω) Chi 1 (χ1) Chi 2 (χ2) Chi 3 (χ3) Chi 4 (χ4) Chi 5 (χ5) Tau (τ) Contacts (colored by PAE) Contact details
1X65.2Low81.7Confident124 Ų124129.5 Ų129.5100%1.27876%0.764SS**  0124.3000000107.8S3G1-S3 PolarHBondContact O-N 3.33Å
2N71.9Confident82.9Confident164 Ų164122.8 Ų122.888%0.87774%0.743SS**  trans-84.691.1174.9-162.3-32.8000107.1G4N2-G4 PolarHBondContact O-N 2.91Å
3S74.4Confident84Confident117 Ų117125.1 Ų125.182%0.81876%0.758SS**  trans-74.677.8173.6-600000107.8X1 G5G1-S3 PolarHBondContact O-N 3.33Å; S3-G5 PolarHBondContact O-N 3.22Å
4G73.4Confident84.9Confident58 Ų58121.9 Ų121.960%0.59876%0.762SS**  trans-68.675.5168.900000109.1N2 Y6N2-G4 PolarHBondContact O-N 2.91Å; G4-Y6 PolarHBondContact O-N 3.28Å
5G79.6Confident85.8Confident53 Ų53119.1 Ų119.155%0.54674%0.744SS.*PPolyproline II helixtrans-66.2122.1172.300000108.7S3 Q7S3-G5 PolarHBondContact O-N 3.22Å; G5-Q7 PolarHBondContact O-N 3.2Å; G5-Q7 VanDerWaalsContact O-N 3.15Å
6Y83.4Confident86.4Confident231 Ų231123.8 Ų123.891%0.90675%0.751SS**PPolyproline II helixtrans-62.3118.2164.6-63.5-77.7000107.8G4 K8G4-Y6 PolarHBondContact O-N 3.28Å; Y6-K8 PolarHBondContact O-N 3.15Å
7Q84.6Confident86.8Confident174 Ų174123.6 Ų123.681%0.81374%0.744SS**PPolyproline II helixtrans-69.1117.2177.3-61-64.379.300108.3G5 V9G5-Q7 PolarHBondContact O-N 3.2Å; G5-Q7 VanDerWaalsContact O-N 3.15Å; Q7-V9 PolarHBondContact O-N 2.82Å
8K87.9Confident87.3Confident180 Ų180126.2 Ų126.278%0.78375%0.746SS**PPolyproline II helixtrans-71.6117.3178.9-174.9-177.7179.3-174.90109.7Y6Y6-K8 PolarHBondContact O-N 3.15Å
9V91.5Very high87.7Confident110 Ų110126.1 Ų126.167%0.66775%0.747SS**PPolyproline II helixtrans-79.6122.5167.2-174.90000108.2Q7 F11Q7-V9 PolarHBondContact O-N 2.82Å; V9-F11 HydrophobicContact CG1-CE1 4.08Å; V9-F11 HydrophobicContact CG1-CE2 3.84Å; V9-F11 HydrophobicContact CG1-CZ 3.51Å
10T93.8Very high88Confident103 Ų103126.6 Ų126.663%0.63274%0.744SS**  trans-118.3133179.1-590000109.5
11F93.2Very high88.2Confident110 Ų110129.4 Ų129.448%0.48277%0.767SS.*  trans-104.8133.1174.5-58.9-75.2000109.6V9 T15 L17V9-F11 HydrophobicContact CG1-CE1 4.08Å; V9-F11 HydrophobicContact CG1-CE2 3.84Å; V9-F11 HydrophobicContact CG1-CZ 3.51Å; F11-T15 HydrophobicContact CB-CG2 3.92Å; F11-T15 HydrophobicContact CG-CG2 4.2Å; F11-T15 HydrophobicContact CD1-CG2 3.84Å; F11-L17 HydrophobicContact CZ-CG 4.45Å; F11-L17 HydrophobicContact CZ-CD2 3.36Å; F11-L17 HydrophobicContact CZ-CD1 4.38Å; F11-L17 HydrophobicContact CD2-CG 4.12Å; F11-L17 HydrophobicContact CG-CG 4.44Å; F11-L17 HydrophobicContact CG-CD2 3.94Å; F11-L17 HydrophobicContact CG-CD1 4.5Å; F11-L17 HydrophobicContact CE2-CG 4.13Å; F11-L17 VanDerWaalsContact CE2-CD2 3.49Å; F11-L17 HydrophobicContact CE2-CD2 3.49Å; F11-L17 HydrophobicContact CE2-CD1 3.66Å; F11-L17 HydrophobicContact CE1-CD2 3.54Å; F11-L17 HydrophobicContact CD2-CD2 3.78Å; F11-L17 HydrophobicContact CD2-CD1 3.73Å; F11-L17 HydrophobicContact CD1-CD2 3.84Å
12G95.9Very high89.3Confident50 Ų50129.7 Ų129.752%0.51574%0.741SS.*  trans-72.8174.7-179.400000113.4G14 T15G12-G14 PolarHBondContact O-N 3.38Å; G12-T15 WeakPolarHBondContact O-CB 3.45Å; G12-T15 PolarHBondContact O-N 3.4Å; G12-T15 PolarHBondContact O-OG1 3.23Å
13T97.1Very high90.2Very high152 Ų152127.9 Ų127.993%0.93373%0.734SS**THydrogen-bonded Turntrans-58.5129.8176.451.40000111T15T13-T15 VanDerWaalsContact C-N 3.34Å
14G97.4Very high91.1Very high80 Ų80128.5 Ų128.583%0.82573%0.729SS**THydrogen-bonded Turntrans86.9-6.9179.200000115.2G12G12-G14 PolarHBondContact O-N 3.38Å
15T97.2Very high92.1Very high80 Ų80132.6 Ų132.649%0.49174%0.737SS.*  trans-73.6131.1175.5-60.30000111.3F11 G12 T13F11-T15 HydrophobicContact CB-CG2 3.92Å; F11-T15 HydrophobicContact CG-CG2 4.2Å; F11-T15 HydrophobicContact CD1-CG2 3.84Å; G12-T15 WeakPolarHBondContact O-CB 3.45Å; G12-T15 PolarHBondContact O-N 3.4Å; G12-T15 PolarHBondContact O-OG1 3.23Å; T13-T15 VanDerWaalsContact C-N 3.34Å
16K95.8Very high92.9Very high195 Ų195137.6 Ų137.685%0.84875%0.749SS**  trans-107.2129.4175.9-63.1178.8-176.81770109.9
17L94Very high93.6Very high120 Ų120131.4 Ų131.463%0.62874%0.738SS**  trans-92.6129172.4-63.5174.8000109.6F11F11-L17 HydrophobicContact CZ-CG 4.45Å; F11-L17 HydrophobicContact CZ-CD2 3.36Å; F11-L17 HydrophobicContact CZ-CD1 4.38Å; F11-L17 HydrophobicContact CD2-CG 4.12Å; F11-L17 HydrophobicContact CG-CG 4.44Å; F11-L17 HydrophobicContact CG-CD2 3.94Å; F11-L17 HydrophobicContact CG-CD1 4.5Å; F11-L17 HydrophobicContact CE2-CG 4.13Å; F11-L17 VanDerWaalsContact CE2-CD2 3.49Å; F11-L17 HydrophobicContact CE2-CD2 3.49Å; F11-L17 HydrophobicContact CE2-CD1 3.66Å; F11-L17 HydrophobicContact CE1-CD2 3.54Å; F11-L17 HydrophobicContact CD2-CD2 3.78Å; F11-L17 HydrophobicContact CD2-CD1 3.73Å; F11-L17 HydrophobicContact CD1-CD2 3.84Å
18Q95.9Very high94.2Very high170 Ų170128.4 Ų128.479%0.79473%0.733SS**  trans-111.9121.8169.7-173.3175.5-64.600108.1
19V94.6Very high94.7Very high124 Ų124124.4 Ų124.475%0.75273%0.729SS**  trans-101.8124.1171.4-178.40000107.3
20I93.1Very high95Very high136 Ų136125.6 Ų125.670%0.69773%0.734SS**  trans-95.8121.5164.6-56.7174000105
21P91.7Very high95.1Very high187 Ų187127.6 Ų127.6100%1.21474%0.744SS**  trans-55.20174.2-2535000113.2

Retrieved 21 of 21 residues in 8.1 ms (Link to these results)

U.S. Privacy Notice - Disclaimer / Registrations / Copyright Statement - Linking Policy - Notice of Privacy Practices (HIPAA) - Notice of Non‑Discrimination
© Copyright 2026 St. Jude Children's Research Hospital, a not-for-profit, section 501(c)(3).